Humana Inc. (HUM) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Me...
Humana Inc. (HUM) currently trades at a P/E ratio of 42.12 (historical range: 15.31–43.71, median: 23.16), placing it at the 97th percentile — expensive relative to its history, P/S ratio of 0.35 (range: 0.15–0.40, 95th percentile — expensive relative to its history), EV/EBITDA of 22.59 (range: 4.52–23.62, 97th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Humana Inc.'s P/E ratio has expanded by 26% over the observed period (from an average of 21.6 to 27.2).
Humana Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 42.12 | 15.31 | 23.16 | 43.71 | 97th | expensive relative to its history |
| P/S Ratio | 0.35 | 0.15 | 0.27 | 0.40 | 95th | expensive relative to its history |
| EV/EBITDA | 22.59 | 4.52 | 8.84 | 23.62 | 97th | expensive relative to its history |
| FCF Yield | 0.02 | 0.01 | 0.04 | 0.11 | 28th | above its historical average |